IL DONG PHARM revenue for the last year amounted to 599.00 B KRW, the most of which — 600.76 B KRW — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 637.71 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought IL DONG PHARM 590.69 B KRW, and the year before that — 623.12 B KRW.